Alberto Chebabo
Impact in
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- COVID-19 Clinical Research Studies 2
- Viral Infections and Vectors 2
-
- Respiratory viral infections research 3
- Pneumonia and Respiratory Infections 2
- Pneumocystis jirovecii pneumonia detection and treatment 1
- Co-authors
- Clóvis Arns da Cunha (4 shared papers)Sérgio Cimerman (4 shared papers)Alfonso J. Rodríguez‐Morales (2 shared papers)Talita Trevizani Rocchetti (1 shared paper)Camila Malta Romano (1 shared paper)José Eduardo Levi (2 shared papers)Antônio Carlos Campos Pignatari (1 shared paper)Ana Cristina Gales (2 shared papers)
In The Last Decade
Alberto Chebabo
11 papers receiving 217 citations
Peers
Comparison fields: 5 of 78
- Molecular Medicine 36
- Applied Microbiology and Biotechnology 8
- Infectious Diseases 64
- Endocrinology 17
- Modeling and Simulation 13
Countries citing papers authored by Alberto Chebabo
This map shows the geographic impact of Alberto Chebabo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Chebabo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Chebabo more than expected).
Fields of papers citing papers by Alberto Chebabo
This network shows the impact of papers produced by Alberto Chebabo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Chebabo. The network helps show where Alberto Chebabo may publish in the future.
Co-authors
The 25 scholars most cited alongside Alberto Chebabo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 67 | |
| 2 | 2014 | 37 | |
| 3 | 2010 | 29 | |
| 4 | 2017 | 17 | |
| 5 | 2016 | 16 | |
| 6 | 2020 | 14 | |
| 7 | 2021 | 12 | |
| 8 | 2010 | 12 | |
| 9 | 2024 | 9 | |
| 10 | 2024 | 7 | |
| 11 | 2023 | 2 | |
| 12 | 2025 | 0 | |
| 13 | 2023 | 0 |
About Alberto Chebabo
Alberto Chebabo is a scholar working on Infectious Diseases, Epidemiology, Public Health, Environmental and Occupational Health, Molecular Medicine and Pharmacology, having authored 13 papers that have together received 222 indexed citations. Recurring topics across this work include Respiratory viral infections research (3 papers), Mosquito-borne diseases and control (2 papers), Pneumonia and Respiratory Infections (2 papers), COVID-19 Clinical Research Studies (2 papers), Viral Infections and Vectors (2 papers), Antibiotic Resistance in Bacteria (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (1 paper) and COVID-19 diagnosis using AI (1 paper). The work is most often cited by research in Molecular Medicine (36 citations), Applied Microbiology and Biotechnology (8 citations), Infectious Diseases (64 citations), Endocrinology (17 citations) and Modeling and Simulation (13 citations). Alberto Chebabo has collaborated with scholars based in Brazil, Colombia and Peru. Frequent co-authors include Clóvis Arns da Cunha, Sérgio Cimerman, Alfonso J. Rodríguez‐Morales, Talita Trevizani Rocchetti, Camila Malta Romano, José Eduardo Levi, Antônio Carlos Campos Pignatari, Ana Cristina Gales, Lígia Câmera Pierrotti and Márcia Garnica. Their work appears in journals such as Brazilian Journal of Medical and Biological Research, Annals of Clinical Microbiology and Antimicrobials, Human Vaccines & Immunotherapeutics, EBioMedicine and Ticks and Tick-borne Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.